» Articles » PMID: 8478057

Induction of Macrophage-mediated Production of Tumor Necrosis Factor Alpha by an L-form Derived from Staphylococcus Aureus

Overview
Journal Infect Immun
Date 1993 May 1
PMID 8478057
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

We investigated the capability of an L-form derived from Staphylococcus aureus to induce tumor necrosis factor alpha (TNF-alpha) production in murine peritoneal macrophages. The activity for TNF-alpha induction was found in the membrane fraction of the L-form but not in the cytoplasmal fraction purified by the sucrose step gradient centrifugation. TNF-alpha mRNA was also detected in macrophages stimulated with L-form membranes. L-form induced TNF-alpha production in macrophages from both lipopolysaccharide-responsive and -unresponsive mouse strains. Regardless of the presence of polymyxin B, the activity of TNF-alpha induction of L-form was mostly found in the phenol layer, but not in the aqueous layer, both of which were prepared by phenol extraction method. Fractions of L-form membranes representing molecular masses of approximately between 29 and 36 kDa were primarily responsible for inducing the production of TNF-alpha consistently. Moreover, this stimulatory effect was abolished by digestion with Streptomyces griseus protease. In Western blot (immunoblot) analysis with anti-lipoteichoic acid antibody, two bands (65 and 45 kDa) were observed in the sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the phenol layer, whereas one band (14 kDa) was observed in either the aqueous layer or lipoteichoic acid of S. aureus. These results suggest that the component in the membrane of the L-form, distinct from cell wall components such as teichoic acid or lipopolysaccharide, possesses the capability to stimulate TNF-alpha production by macrophages.

Citing Articles

Proteins of 30 and 36 kilodaltons, membrane constituents of the Staphylococcus aureus L form, induce production of tumor necrosis factor alpha and activate the human immunodeficiency virus type 1 long terminal repeat.

Akashi A, Ono S, Kuwano K, Arai S Infect Immun. 1996; 64(8):3267-72.

PMID: 8757863 PMC: 174217. DOI: 10.1128/iai.64.8.3267-3272.1996.


Capsular polysaccharide types 5 and 8 of Staphylococcus aureus bind specifically to human epithelial (KB) cells, endothelial cells, and monocytes and induce release of cytokines.

Soell M, Diab M, Beretz A, Herbelin C, Poutrel B, Klein J Infect Immun. 1995; 63(4):1380-6.

PMID: 7890398 PMC: 173162. DOI: 10.1128/iai.63.4.1380-1386.1995.


Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.

de Kimpe S, Hunter M, Bryant C, Thiemermann C, Vane J Br J Pharmacol. 1995; 114(6):1317-23.

PMID: 7542534 PMC: 1510350. DOI: 10.1111/j.1476-5381.1995.tb13349.x.

References
1.
Gutman L, Turck M, Petersdorf R, Wedgwood R . Significance of bacterial variants in urine of patients with chronic bacteriuria. J Clin Invest. 1965; 44(12):1945-52. PMC: 289696. DOI: 10.1172/JCI105300. View

2.
Belsheim M, Darwish R, Watson W, Schieven B . Bacterial L-form isolation from inflammatory bowel disease patients. Gastroenterology. 1983; 85(2):364-9. View

3.
Pratt B . Cell-wall deficiencies in L-forms of Staphylococcus aureus. J Gen Microbiol. 1966; 42(1):115-22. DOI: 10.1099/00221287-42-1-115. View

4.
Roberts R, WITTLER R . The L form of Neisseria meningitidis. J Gen Microbiol. 1966; 44(1):139-48. DOI: 10.1099/00221287-44-1-139. View

5.
WEIBULL C, Bickel W, HASKINS W, MILNER K, Ribi E . Chemical, biological, and structural properties of stable Proteus L forms and their parent bacteria. J Bacteriol. 1967; 93(3):1143-59. PMC: 276564. DOI: 10.1128/jb.93.3.1143-1159.1967. View